US Stock MarketDetailed Quotes

AIMT Aimmune Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)

Aimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
(Q1)Mar 31, 2019
(FY)Dec 31, 2018
(Q4)Dec 31, 2018
(Q3)Sep 30, 2018
Total revenue
0
575K
0
0
0
0
0
0
0
0
Operating revenue
--0
--575K
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
4.85M
257K
0
0
Gross profit
-4.85M
318K
0
0
Operating expense
-3.24%61.14M
55.56%85.6M
16.00%249.8M
14.64%66.99M
21.95%64.6M
17.42%63.19M
9.79%55.03M
61.58%215.34M
40.33%58.43M
64.07%52.98M
Selling and administrative expenses
22.10%38.09M
107.23%49.14M
53.58%125.82M
45.10%36.86M
59.94%34.04M
68.11%31.2M
42.22%23.71M
86.40%81.92M
95.63%25.4M
89.60%21.29M
-General and administrative expense
22.10%38.09M
107.23%49.14M
53.58%125.82M
45.10%36.86M
59.94%34.04M
68.11%31.2M
42.22%23.71M
86.40%81.92M
95.63%25.4M
89.60%21.29M
Research and development costs
-27.95%23.05M
16.44%36.46M
-7.07%123.99M
-8.79%30.13M
-3.58%30.56M
-9.26%31.99M
-6.37%31.32M
49.36%133.42M
15.27%33.03M
50.46%31.69M
Operating profit
-4.44%-65.99M
-54.98%-85.28M
-16.00%-249.8M
-14.64%-66.99M
-21.95%-64.6M
-17.42%-63.19M
-9.79%-55.03M
-61.58%-215.34M
-40.33%-58.43M
-64.07%-52.98M
Net non-operating interest income expense
-721.43%-2.78M
-265.26%-1.25M
-80.80%935K
-115.69%-257K
-96.70%43K
-65.38%448K
19.03%757K
134.63%4.87M
172.55%1.64M
162.17%1.3M
Non-operating interest income
-74.97%428K
-48.55%978K
17.40%5.85M
166.08%4.66M
-96.70%43K
32.15%1.71M
198.90%1.9M
127.58%4.98M
144.90%1.75M
162.17%1.3M
Non-operating interest expense
154.52%3.21M
94.84%2.23M
4,250.44%4.92M
----
----
--1.26M
--1.14M
-0.88%113K
----
----
Other net income (expense)
-64.44%-148K
550.00%221K
592.31%1.09M
-90K
34K
-211.27%-221K
Other non- operating income (expenses)
-64.44%-148K
550.00%221K
592.31%1.09M
----
----
---90K
--34K
-211.27%-221K
----
----
Income before tax
-9.70%-68.92M
-59.14%-86.31M
-17.60%-247.78M
-16.03%-66.16M
-24.94%-64.56M
-19.63%-62.83M
-9.61%-54.24M
-60.50%-210.69M
-38.69%-57.02M
-62.53%-51.67M
Income tax
568.75%321K
310.34%119K
1,073.77%716K
4,227.78%743K
-458.62%-104K
45.45%48K
70.59%29K
8.93%61K
-132.14%-18K
29K
Net income
-10.12%-69.24M
-59.27%-86.43M
-17.91%-248.5M
-17.37%-66.9M
-24.67%-64.46M
-19.65%-62.88M
-9.63%-54.27M
-60.48%-210.75M
-38.46%-57M
-62.63%-51.7M
Net income continuous Operations
-10.12%-69.24M
-59.27%-86.43M
-17.91%-248.5M
-17.37%-66.9M
-24.67%-64.46M
-19.65%-62.88M
-9.63%-54.27M
-60.48%-210.75M
-38.46%-57M
-62.63%-51.7M
Minority interest income
Net income attributable to the parent company
-10.12%-69.24M
-59.27%-86.43M
-17.91%-248.5M
-17.37%-66.9M
-24.67%-64.46M
-19.65%-62.88M
-9.63%-54.27M
-60.48%-210.75M
-38.46%-57M
-62.63%-51.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.12%-69.24M
-59.27%-86.43M
-17.91%-248.5M
-17.37%-66.9M
-24.67%-64.46M
-19.65%-62.88M
-9.63%-54.27M
-60.48%-210.75M
-38.46%-57M
-62.63%-51.7M
Basic earnings per share
-4.95%-1.06
-54.02%-1.34
-8.17%-3.97
-11.58%-1.06
-15.73%-1.03
-10.99%-1.01
5.43%-0.87
-40.61%-3.67
-15.85%-0.95
-41.27%-0.89
Diluted earnings per share
-4.95%-1.06
-54.02%-1.34
-8.17%-3.97
-11.58%-1.06
-15.73%-1.03
-10.99%-1.01
5.43%-0.87
-40.61%-3.67
-15.85%-0.95
-41.27%-0.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019(Q2)Jun 30, 2019(Q1)Mar 31, 2019(FY)Dec 31, 2018(Q4)Dec 31, 2018(Q3)Sep 30, 2018
Total revenue 0575K00000000
Operating revenue --0--575K--0--0--0--0--0--0--0--0
Cost of revenue 4.85M257K00
Gross profit -4.85M318K00
Operating expense -3.24%61.14M55.56%85.6M16.00%249.8M14.64%66.99M21.95%64.6M17.42%63.19M9.79%55.03M61.58%215.34M40.33%58.43M64.07%52.98M
Selling and administrative expenses 22.10%38.09M107.23%49.14M53.58%125.82M45.10%36.86M59.94%34.04M68.11%31.2M42.22%23.71M86.40%81.92M95.63%25.4M89.60%21.29M
-General and administrative expense 22.10%38.09M107.23%49.14M53.58%125.82M45.10%36.86M59.94%34.04M68.11%31.2M42.22%23.71M86.40%81.92M95.63%25.4M89.60%21.29M
Research and development costs -27.95%23.05M16.44%36.46M-7.07%123.99M-8.79%30.13M-3.58%30.56M-9.26%31.99M-6.37%31.32M49.36%133.42M15.27%33.03M50.46%31.69M
Operating profit -4.44%-65.99M-54.98%-85.28M-16.00%-249.8M-14.64%-66.99M-21.95%-64.6M-17.42%-63.19M-9.79%-55.03M-61.58%-215.34M-40.33%-58.43M-64.07%-52.98M
Net non-operating interest income expense -721.43%-2.78M-265.26%-1.25M-80.80%935K-115.69%-257K-96.70%43K-65.38%448K19.03%757K134.63%4.87M172.55%1.64M162.17%1.3M
Non-operating interest income -74.97%428K-48.55%978K17.40%5.85M166.08%4.66M-96.70%43K32.15%1.71M198.90%1.9M127.58%4.98M144.90%1.75M162.17%1.3M
Non-operating interest expense 154.52%3.21M94.84%2.23M4,250.44%4.92M----------1.26M--1.14M-0.88%113K--------
Other net income (expense) -64.44%-148K550.00%221K592.31%1.09M-90K34K-211.27%-221K
Other non- operating income (expenses) -64.44%-148K550.00%221K592.31%1.09M-----------90K--34K-211.27%-221K--------
Income before tax -9.70%-68.92M-59.14%-86.31M-17.60%-247.78M-16.03%-66.16M-24.94%-64.56M-19.63%-62.83M-9.61%-54.24M-60.50%-210.69M-38.69%-57.02M-62.53%-51.67M
Income tax 568.75%321K310.34%119K1,073.77%716K4,227.78%743K-458.62%-104K45.45%48K70.59%29K8.93%61K-132.14%-18K29K
Net income -10.12%-69.24M-59.27%-86.43M-17.91%-248.5M-17.37%-66.9M-24.67%-64.46M-19.65%-62.88M-9.63%-54.27M-60.48%-210.75M-38.46%-57M-62.63%-51.7M
Net income continuous Operations -10.12%-69.24M-59.27%-86.43M-17.91%-248.5M-17.37%-66.9M-24.67%-64.46M-19.65%-62.88M-9.63%-54.27M-60.48%-210.75M-38.46%-57M-62.63%-51.7M
Minority interest income
Net income attributable to the parent company -10.12%-69.24M-59.27%-86.43M-17.91%-248.5M-17.37%-66.9M-24.67%-64.46M-19.65%-62.88M-9.63%-54.27M-60.48%-210.75M-38.46%-57M-62.63%-51.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.12%-69.24M-59.27%-86.43M-17.91%-248.5M-17.37%-66.9M-24.67%-64.46M-19.65%-62.88M-9.63%-54.27M-60.48%-210.75M-38.46%-57M-62.63%-51.7M
Basic earnings per share -4.95%-1.06-54.02%-1.34-8.17%-3.97-11.58%-1.06-15.73%-1.03-10.99%-1.015.43%-0.87-40.61%-3.67-15.85%-0.95-41.27%-0.89
Diluted earnings per share -4.95%-1.06-54.02%-1.34-8.17%-3.97-11.58%-1.06-15.73%-1.03-10.99%-1.015.43%-0.87-40.61%-3.67-15.85%-0.95-41.27%-0.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg